Amgen

AMGN US Health Care Biotechnology
S&P 500 Nasdaq 100 Dow Jones
$377.35
-1.34%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Comfortable interest cover: operating profit covers interest about 3.3 times.
  • Return on equity is healthy at 66%.
  • Return on capital employed is moderate at 12.9%.
  • Net profit margin is strong at 21%.
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Higher leverage: debt-to-equity of 4.67 is above 1.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Piotroski F-ScoreStrong
7 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$204.01B
Current Price$ 377.35
High / Low$ 447.03 / 269.77
Stock P/E23.42334
Book Value$ 21.49
Dividend Yield2.56%
ROCE12.94%
ROE65.97%
Debt to Equity4.67
Current Ratio1.14
P/B Ratio17.453747
EPS$ 14.23
Debt$54.60B
PAT Margin20.98%
Cash PAT$12.88B
ICR3.30
Educational data only. Not a recommendation to buy, sell or hold any security.